This suggested a mechanism by which Alox15 and Alox12 could promote AAA development, where eoxPL generated at the vessel wall during lesion progression provide a procoagulant surface for clotting factor binding and activation. This evidence concerns the gene ALOX15 and triple-A syndrome.